Eperezolid, CAS [[165800-04-4]]

Produktübersicht

• Artikelname: Eperezolid, CAS [[165800-04-4]]
• Artikelnummer: MCE-HY-10393
• Hersteller Artikelnummer: HY-10393
• Alternativnummer: MCE-HY-10393-100MG,MCE-HY-10393-10MG,MCE-HY-10393-10MMX1ML,MCE-HY-10393-5MG,MCE-HY-10393-50MG,MCE-HY-10393-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: PNU-100592

Produktbeschreibung

Eperezolid (PNU-100592) is an orally active protein synthesis inhibitor that targets the bacterial 50S ribosomal subunit. Eperezolid competitively binds to a specific site on the ribosomal 50S subunit (overlapping with the binding sites of chloramphenicol (HY-B0239) and lincomycin (HY-117660)) to inhibit the translation initiation stage and exert antibacterial activity. Eperezolid can induce host cell autophagy to enhance the clearance of intracellular mycobacteria, and its MIC90 for Staphylococcus aureus and Enterococcus is 1-4 µg/mL. Eperezolid is mainly used for antibacterial research on infections with Gram-positive bacteria such as methicillin-resistant (HY-121544) Staphylococci and vancomycin-resistant (HY-B0671) Enterococci, as well as infections with intracellular bacteria such as Mycobacterium tuberculosis[1][2][3][4].

Produkteigenschaften

• Molekulargewicht: 394.40
• Reinheit: 96.55
• CAS Nummer: [165800-04-4]
• Formel: C18H23FN4O5
• Target-Kategorie: Antibiotic,Bacterial

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound1